Comparative Efficacy of Ibrutinib Versus Obinutuzumab + Chlorambucil in First-Line Treatment of Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect Comparison
Crossref DOI link: https://doi.org/10.1007/s12325-017-0564-1
Published Online: 2017-06-01
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Van Sanden, Suzy
Baculea, Simona
Diels, Joris
Cote, Sarah
Funding for this research was provided by:
Janssen Pharmaceuticals
Text and Data Mining valid from 2017-06-01
Article History
Received: 3 April 2017
First Online: 1 June 2017